Genetic clues link lipoprotein A to prostate cancer risk

October 15, 2024 0 Comments 0 tags

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of

New blood test combined with image-based prostate cancer screening reduces harms and costs

October 15, 2024 0 Comments 0 tags

The combination of a novel blood test and magnetic resonance imaging (MRI) can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a

Ultrasound scan can diagnose prostate cancer

October 15, 2024 0 Comments 0 tags

An ultrasound scan can be used to detect cases of prostate cancer, according to new research. Researchers at Imperial College London, University College London and Imperial College Healthcare NHS Trust

In pilot study, asynchronous telehealth visits effectively treat overactive bladder

October 14, 2024 0 Comments 0 tags

Women who received treatment for overactive bladder (OAB) using asynchronous telehealth visits had significant improvement in their symptoms and high satisfaction with their care, concludes an exploratory pilot study published

Metastatic prostate cancer on the rise since decrease in cancer screenings

October 14, 2024 0 Comments 0 tags

A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against

Cause of metastasis in prostate cancer discovered

October 14, 2024 0 Comments 0 tags

Prostate cancers remain localised in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, resulting in approximately

Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases

October 14, 2024 0 Comments 0 tags

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with

New combined therapy helps extend lives of men with prostate cancer

October 14, 2024 0 Comments 0 tags

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy — a commonly used hormone injection — plus pelvic lymph node radiation, kept nearly 90% of clinical

High-intensity focused ultrasound (HIFU) can control prostate cancer with fewer side effects

October 14, 2024 0 Comments 0 tags

In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be “intermediate risk” — mostly, small tumors confined to

Prostate cancer cases risk being detected too late due to misleading focus on urinary problems

October 14, 2024 0 Comments 0 tags

Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a lack